HIF 1 ALPHA AND PHOS S6 ARE INDEPENDENT PREDICTORS OF SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC)

被引：0
|
作者：
Schultz, Luciana
Albadine, Roula
Hicks, Jessica
De Marzo, Angelo
Reuter, Victor
Carducci, Michael
Pili, Roberto
Argani, Pedram
Netto, George
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
201
引用
收藏
页码：E80 / E80
页数：1
相关论文
共 50 条
  • [21] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [22] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    LABORATORY INVESTIGATION, 2013, 93 : 196A - 196A
  • [23] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    MODERN PATHOLOGY, 2013, 26 : 196A - 196A
  • [24] mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Bastos, Diogo Assed
    Voss, Martin Henner
    Karlo, Christoph
    Ajeti, Albulena
    Patil, Sujata
    Feldman, Darren Richard
    Molina, Ana M.
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [25] DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC)
    Evelonn, Emma Andersson
    Degerman, Sofie
    Kohn, Linda
    Landfors, Mattias
    Ljungberg, Borje
    Roos, Goran
    TUMOR BIOLOGY, 2016, 37 (08) : 10219 - 10228
  • [26] The VHL/HIF axis in clear cell renal carcinoma
    Shen, Chuan
    Kaelin, William G., Jr.
    SEMINARS IN CANCER BIOLOGY, 2013, 23 (01) : 18 - 25
  • [27] Genomic and clinical determinants of recurrence in localized clear cell renal cell carcinoma (ccRCC).
    Bakouny, Ziad
    Abou Alaiwi, Sarah
    Nassar, Amin
    Flippot, Ronan
    Nuzzo, Pier Vitale
    Bosse, Dominick
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Harshman, Lauren Christine
    Signoretti, Sabina
    Kwiatkowski, David J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC)
    Liu, Shiyi
    Li, Saijiao
    Wang, Yanqing
    Wang, Feiyan
    Zhang, Li
    Xian, Shu
    Yang, Dongyong
    Yuan, Mengqin
    Dai, Fangfang
    Zhao, Xin
    Liu, Yuping
    Jin, Yumeng
    Zeng, Zihang
    Mahgoub, Omer Kamal Ahmed
    Zhou, Chenliang
    Cheng, Yanxiang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (03) : 2571 - 2581
  • [29] Membrane-bound peptidase activity in clear cell renal cell carcinoma (CCRCC)
    Etxezarraga, C.
    Varona, A.
    Larrinaga, G.
    Gil, J.
    Hoyos, I.
    Lopez, J. I.
    LABORATORY INVESTIGATION, 2007, 87 : 347A - 347A
  • [30] Perinephric white adipose tissue inflammation in clear cell renal cell carcinoma (ccRCC).
    Furberg, Helena
    Hakimi, A. Ari
    Gucalp, Ayca
    Iyengar, Neil M.
    Williams, Samantha
    Petruzella, Stacey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345